1. Home
  2. USAC vs ACLX Comparison

USAC vs ACLX Comparison

Compare USAC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USAC

USA Compression Partners LP

HOLD

Current Price

$27.65

Market Cap

4.0B

Sector

Utilities

ML Signal

HOLD

Logo Arcellx Inc.

ACLX

Arcellx Inc.

HOLD

Current Price

$114.01

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAC
ACLX
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.7B
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
USAC
ACLX
Price
$27.65
$114.01
Analyst Decision
Hold
Hold
Analyst Count
4
15
Target Price
$26.75
$115.85
AVG Volume (30 Days)
187.3K
3.5M
Earning Date
05-20-2026
01-01-0001
Dividend Yield
7.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$698,365,000.00
$22,286,000.00
Revenue This Year
$26.04
$480.59
Revenue Next Year
$9.86
$88.40
P/E Ratio
$31.25
N/A
Revenue Growth
19.51
N/A
52 Week Low
$21.59
$47.86
52 Week High
$28.09
$114.26

Technical Indicators

Market Signals
Indicator
USAC
ACLX
Relative Strength Index (RSI) 66.05 83.63
Support Level $22.62 $64.61
Resistance Level N/A $114.26
Average True Range (ATR) 0.75 1.84
MACD 0.04 4.89
Stochastic Oscillator 97.21 99.50

Price Performance

Historical Comparison
USAC
ACLX

About USAC USA Compression Partners LP

USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Share on Social Networks: